Sarah Cappuyns

405 total citations · 1 hit paper
12 papers, 205 citations indexed

About

Sarah Cappuyns is a scholar working on Oncology, Molecular Biology and Hepatology. According to data from OpenAlex, Sarah Cappuyns has authored 12 papers receiving a total of 205 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Hepatology. Recurrent topics in Sarah Cappuyns's work include Cancer Immunotherapy and Biomarkers (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Immune cells in cancer (3 papers). Sarah Cappuyns is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Immune cells in cancer (3 papers). Sarah Cappuyns collaborates with scholars based in Belgium, United States and Spain. Sarah Cappuyns's co-authors include Josep M. Llovet, Mark Yarchoan, Richard S. Finn, Virginia Corbett, Jeroen Dekervel, Chris Verslype, Eric Van Cutsem, Diether Lambrechts, Jos van Pelt and Tania Roskams and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Sarah Cappuyns

10 papers receiving 205 citations

Hit Papers

Critical Appraisal of Guideline Recommendations on System... 2023 2026 2024 2025 2023 20 40 60
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma
    2023 72 citations Sarah Cappuyns, Virginia Corbett et al. JAMA Oncology profile →

Peers

Sarah Cappuyns
Roger Esteban-Fabró Spain
Yichuan Yuan China
Motohiro Kojima Japan
Yoshimoto Nomura Japan
Ruiqi Wu China
Patricia Rich United States
Tanuj Banker United States
Zu-Shun Chen China
Youpei Lin China
Marie Mack United States
Roger Esteban-Fabró Spain
Sarah Cappuyns
Citations per year, relative to Sarah Cappuyns Sarah Cappuyns (= 1×) peers Roger Esteban-Fabró

Countries citing papers authored by Sarah Cappuyns

Since Specialization
Citations

This map shows the geographic impact of Sarah Cappuyns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Cappuyns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Cappuyns more than expected).

Fields of papers citing papers by Sarah Cappuyns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Cappuyns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Cappuyns. The network helps show where Sarah Cappuyns may publish in the future.

Co-authorship network of co-authors of Sarah Cappuyns

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Cappuyns. A scholar is included among the top collaborators of Sarah Cappuyns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Cappuyns. Sarah Cappuyns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Deman, Frederik, et al.. (2025). Claudin-18.2 expression in gastro-oesophageal adenocarcinoma in a Western population: Overlap with other biomarkers and prognostic value.. Journal of Clinical Oncology. 43(16_suppl). 4021–4021.
2.
Wu, Linda Y., Sarah Cappuyns, Sara Lewis, et al.. (2024). Impact of underlying liver disease on unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors. PubMed. 2(1). 8–8. 6 indexed citations
3.
Cappuyns, Sarah, et al.. (2024). Applications of single-cell multi-omics in liver cancer. JHEP Reports. 6(7). 101094–101094. 6 indexed citations
4.
Lindblad, Katherine E., Romain Donné, Marina Bárcena‐Varela, et al.. (2024). NOTCH1 Drives Sexually Dimorphic Immune Responses in Hepatocellular Carcinoma. Cancer Discovery. 15(3). 495–510. 5 indexed citations
5.
6.
Cappuyns, Sarah, Vincent Vandecaveye, Bram Boeckx, et al.. (2023). PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma. Nature Communications. 14(1). 7825–7825. 33 indexed citations
7.
Kinget, Lisa, et al.. (2023). Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma. Cancers. 15(2). 348–348. 14 indexed citations
8.
Cappuyns, Sarah, Virginia Corbett, Mark Yarchoan, Richard S. Finn, & Josep M. Llovet. (2023). Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma. JAMA Oncology. 10(3). 395–395. 72 indexed citations breakdown →
9.
Cappuyns, Sarah, Vincent Vandecaveye, Chris Verslype, et al.. (2022). Pre-treatment cross-talk between the tumoural and peripheral immune system predicts response to checkpoint inhibition in advanced HCC: a single-cell study. Journal of Hepatology. 77. S385–S385. 1 indexed citations
10.
11.
Cappuyns, Sarah, et al.. (2022). Case report: Two sisters with light-chain cardiac amyloidosis, a mere coincidence?. European Heart Journal - Case Reports. 6(2). ytac084–ytac084.
12.
Galle, Eva, Bernard Thienpont, Sarah Cappuyns, et al.. (2020). DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer. Clinical Epigenetics. 12(1). 27–27. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roger Esteban-Fabró Breakdown of academic impact, for papers by Yichuan Yuan Breakdown of academic impact, for papers by Motohiro Kojima Breakdown of academic impact, for papers by Yoshimoto Nomura Breakdown of academic impact, for papers by Ruiqi Wu Breakdown of academic impact, for papers by Patricia Rich Breakdown of academic impact, for papers by Tanuj Banker Breakdown of academic impact, for papers by Zu-Shun Chen Breakdown of academic impact, for papers by Youpei Lin Breakdown of academic impact, for papers by Marie Mack
Rankless by CCL
2026